FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Françoise Bressolle

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Moxisylyte

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Sylvain Poujol; K Bekhtari; Françoise Bressolle; M Dell'ova; Frédéric Pinguet
Stability of the ready-to-use solutions of eribulin for intravenous infusion.
Sylvain Poujol; Isabelle Solassol; Françoise Bressolle; Frédéric Pinguet
Stability of ready-to-use temsirolimus infusion solution (100mg/L) in polypropylene containers under different storage conditions.
Pierre-Emmanuel Colombo; Marta Jarlier; Maha-Zohra Ladjemi; Frédéric Pinguet; Sylvain Poujol; Philippe Rouanet; Isabelle Teulon; Mahfoud Boustta; Françoise Bressolle; Michel Vert
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Françoise Bressolle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sylvain Poujol; K Bekhtari; Françoise Bressolle; M Dell'ova; Frédéric Pinguet
Stability of the ready-to-use solutions of eribulin for intravenous infusion.
Annales pharmaceutiques françaises 2012;70(5):249-55.
2012: Sylvain Poujol; Isabelle Solassol; Françoise Bressolle; Frédéric Pinguet
Stability of ready-to-use temsirolimus infusion solution (100mg/L) in polypropylene containers under different storage conditions.
Annales pharmaceutiques françaises 2012;70(3):155-62.
2011: Pierre-Emmanuel Colombo; Marta Jarlier; Maha-Zohra Ladjemi; Frédéric Pinguet; Sylvain Poujol; Philippe Rouanet; Isabelle Teulon; Mahfoud Boustta; Françoise Bressolle; Michel Vert
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer.
Gynecologic oncology 2011;122(3):632-40.
2011: Françoise Bressolle; S Khier; A Rochette; JM Kinowski; C Dadure; Xavier Capdevila
Population pharmacokinetics of nalbuphine after surgery in children.
British journal of anaesthesia 2011;106(4):558-65.
2011: Delphine Margout; Florence Gattacceca; Georges MOARBESS; Sharon Wein; Christophe Tran van Ba; Samuel Le Pape; Olivier Berger; Roger Escale; Henri VIAL; Françoise Bressolle
Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2011;42(1-2):81-90.
2010: Sonia Khier; Florence Gattacceca; Safia El Messaoudi; Florian Lafaille; Carine Deleuze-Masquéfa; Jacques Bompart; Jean-François Cooper; Isabelle Solassol; Frédéric Pinguet; Pierre-Antoine Bonnet; Françoise Bressolle
Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas.
Drug metabolism and disposition: the biological fate of chemicals 2010;38(10):1836-47.
2010: Sonia Khier; Carine Deleuze-Masquéfa; Georges MOARBESS; Florence Gattacceca; Delphine Margout; Isabelle Solassol; Jean-François Cooper; Frédéric Pinguet; Pierre-Antoine Bonnet; Françoise Bressolle
Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2010;39(1-3):23-9.
2009: Carine Deleuze-Masquefa; Georges MOARBESS; Sonia Khier; Nadège David; Stéphanie Gayraud-Paniagua; Françoise Bressolle; Frédéric Pinguet; Pierre-Antoine Bonnet
New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
European journal of medicinal chemistry 2009;44(9):3406-11.
2009: Delphine Margout; N Bontemps; Clemens H M Kocken; Henri VIAL; Françoise Bressolle
Rapid resolution liquid chromatography-mass spectrometry determination of SAR97276 in monkey matrices. Pharmacokinetics in rhesus monkey infected by Plasmodium cynomolgi.
Journal of pharmaceutical and biomedical analysis 2009;49(5):1266-71.
2009: Delphine Margout; Sharon Wein; Hermine Gandon; Florence Gattacceca; Henri VIAL; Françoise Bressolle
Quantitation of SAR97276 in mouse tissues by rapid resolution liquid chromatography-mass spectrometry.
Journal of separation science 2009;32(11):1808-15.
2009: Sonia Khier; Georges MOARBESS; Carine Deleuze-Masquefa; Isabelle Solassol; Delphine Margout; Frédéric Pinguet; Pierre-Antoine Bonnet; Françoise Bressolle
Quantitation of imidazo[1,2-a]quinoxaline derivatives in human and rat plasma using LC/ESI-MS.
Journal of separation science 2009;32(9):1363-73.
2009: Françoise Bressolle; A Rochette; S Khier; C Dadure; J Ouaki; Xavier Capdevila
Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children.
British journal of anaesthesia 2009;102(3):390-9.
2008: Nicolas Taudon; Delphine Margout; Michèle Calas; T Kezutyte; Henri VIAL; Françoise Bressolle
A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
Journal of pharmaceutical and biomedical analysis 2008;48(3):1001-5.
2008: Rūta Svobaite; Isabelle Solassol; Frédéric Pinguet; Liudas Ivanauskas; JC Brès; Françoise Bressolle
HPLC with UV or mass spectrometric detection for quantifying endogenous uracil and dihydrouracil in human plasma.
Clinical chemistry 2008;54(9):1463-72.
2008: Véronique Sinou; Nicolas Taudon; Joël Mosnier; Christian Aglioni; Françoise Bressolle; Daniel Parzy
Pharmacokinetics of artesunate in the domestic pig.
The Journal of antimicrobial chemotherapy 2008;62(3):566-74.
2008: Georges MOARBESS; Carine Deleuze-Masquefa; Vanessa Bonnard; Stéphanie Gayraud-Paniagua; Jean-Rémi Vidal; Françoise Bressolle; Frédéric Pinguet; Pierre-Antoine Bonnet
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives.
Bioorganic & medicinal chemistry 2008;16(13):6601-10.
2008: Nicolas Taudon; Delphine Margout; Sharon Wein; Michèle Calas; Henri VIAL; Françoise Bressolle
Quantitative analysis of a bis-thiazolium antimalarial compound, SAR97276, in mouse plasma and red blood cell samples, using liquid chromatography mass spectrometry.
Journal of pharmaceutical and biomedical analysis 2008;46(1):148-56.
2007: Sylvain Poujol; Frédéric Pinguet; Marc Ychou; Anissa Gauthey Abderrahim; Jacqueline Duffour; Françoise Bressolle
A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimen.
Oncology reports 2007;18(6):1613-321.
2007: Christine Plard; Christine Piard; Françoise Bressolle; May Fakhoury; Daolun Zhang; Karina Yacouben; andre RIEUTORD; Evelyne Jacqz-Aigrain
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
Cancer chemotherapy and pharmacology 2007;60(4):609-20.
2007: Pierre-Emmanuel Colombo; Mahfoud Boustta; Sylvain Poujol; Frédéric Pinguet; Philippe Rouanet; Françoise Bressolle; Michel Vert
Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2007;31(1):43-52.
2007: Magali Bolon-Larger; Valérie Chamouard; Françoise Bressolle; Roselyne Boulieu
A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
Therapeutic drug monitoring 2007;29(1):20-6.
2006: Violeta Kontrimaviciūte; Hélène Breton; Olivier Mathieu; Jean-Claude Mathieu-Daudé; Françoise Bressolle
Liquid chromatography-electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole blood. Application to a poisoning involving Tabernanthe iboga root.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;843(2):131-41.
2006: J Groeschke; Isabelle Solassol; Françoise Bressolle; Frédéric Pinguet
Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate.
Journal of pharmaceutical and biomedical analysis 2006;42(3):362-6.
2006: Violeta Kontrimaviciūte; Olivier Mathieu; Jean-Claude Mathieu-Daudé; Paulius Vainauskas; Thierry Casper; Eric Baccino; Françoise Bressolle
Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub.
Journal of analytical toxicology 2006;30(7):434-40.
2006: Sylvain Poujol; Françoise Bressolle; Jacqueline Duffour; Anissa Gauthey Abderrahim; Cécile Astre; Marc Ychou; Frédéric Pinguet
Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen.
Cancer chemotherapy and pharmacology 2006;58(3):292-305.
2006: Philippe Mougenot; Françoise Bressolle; Stéphane Culine; Isabelle Solassol; Sylvain Poujol; Frédéric Pinguet
In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancer.
Anticancer research 2006;26(3B):2197-203.
2006: Olivier Mathieu; Dominique Hillaire-Buys; Christophe Dadure; Franck Barnay; Jean-Claude Mathieu-Daudé; Françoise Bressolle
Liquid chromatography-electrospray mass spectrometry determination of free and total concentrations of ropivacaine in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;831(1-2):91-8.
2006: Philippe Mougenot; Michel Fabbro; Françoise Bressolle; Damien Pouessel; Stéphane Culine; Frédéric Pinguet
Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancer.
Oncology reports 2006;15(1):237-41.
2005: Hélène Breton; Marylène Cociglio; Françoise Bressolle; Hélène Peyriere; Jean-Pierre Blayac; Dominique Hillaire-Buys
Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;828(1-2):80-90.
2005: Isabelle Solassol; Laetitia Caumette; Françoise Bressolle; Frédéric Garcia; Simon Thézenas; Cécile Astre; Stéphane Culine; Rémi Coulouma; Frédéric Pinguet
Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
Oncology reports 2005;14(4):1029-36.
2005: Olivier Nicolas; Delphine Margout; Nicolas Taudon; Sharon Wein; Michèle Calas; Henri VIAL; Françoise Bressolle
Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3.
Antimicrobial agents and chemotherapy 2005;49(9):3631-9.
2005: Violeta Kontrimaviciūte; Michel Larroque; Vitalis Briedis; Delphine Margout; Françoise Bressolle
Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;822(1-2):285-93.
2005: Isabelle Solassol; Françoise Bressolle; Laetitia Caumette; Frédéric Garcia; Sylvain Poujol; Stéphane Culine; Frédéric Pinguet
Inter- and intraindividual variabilities in pharmacokinetics of fentanyl after repeated 72-hour transdermal applications in cancer pain patients.
Therapeutic drug monitoring 2005;27(4):491-8.
2005: Olivier Nicolas; Delphine Margout; Nicolas Taudon; Michèle Calas; Henri VIAL; Françoise Bressolle
Liquid chromatography-electrospray mass spectrometry determination of a bis-thiazolium compound with potent antimalarial activity and its neutral bioprecursor in human plasma, whole blood and red blood cells.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;820(1):83-93.
2005: Salomee Payen; Daolun Zhang; Anne Maisin; Michel Popon; Albert Bensman; François Bouissou; Chantal Loirat; Roberto Gomeni; Françoise Bressolle; Evelyne Jacqz-Aigrain
Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients.
Therapeutic drug monitoring 2005;27(3):378-88.
2005: Sharon Wein; Michèle Calas; Françoise Bressolle; Socrates Herrera; Alan Thomas; Henri VIAL
[Malaria: towards a new treatment!].
Médecine sciences : M/S 2005;21(4):341-3.
2005: Olivier Nicolas; Christine Farenc; Michèle Calas; Henri VIAL; Françoise Bressolle
Quantification of antimalarial bisthiazolium compounds and their neutral bioprecursors in plasma by liquid chromatography-electrospray mass spectrometry.
Clinical chemistry 2005;51(3):593-602.
2005: Salomee Payen; Albert Faye; Alexandra Compagnucci; Carlo Giaquinto; Diana Gibbs; Roberto Gomeni; Françoise Bressolle; Evelyne Jacqz-Aigrain
Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy 2005;49(2):525-35.
2004: Henri VIAL; Sharon Wein; Christine Farenc; Clemens H M Kocken; Olivier Nicolas; Marie Laure Ancelin; Françoise Bressolle; Alan Thomas; Michèle Calas
Prodrugs of bisthiazolium salts are orally potent antimalarials.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(43):15458-63.
2004: Philippe Mougenot; Frédéric Pinguet; Michel Fabbro; Stéphane Culine; Sylvain Poujol; Cécile Astre; Françoise Bressolle
Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies.
Cancer chemotherapy and pharmacology 2004;53(6):503-12.
2004: K Zurbonsen; Françoise Bressolle; Isabelle Solassol; Pierre-Jean Aragon; Stéphane Culine; Frédéric Pinguet
Simultaneous determination of dexamethasone and 6 beta-hydroxydexamethasone in urine using solid-phase extraction and liquid chromatography: applications to in vivo measurement of cytochrome P450 3A4 activity.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;804(2):421-9.
2004: Aurélie Gaudard; Emmanuelle Varlet-Marie; Françoise Bressolle; Jacques Mercier; Jean-Frédéric Brun
Nutrition as a determinant of blood rheology and fibrinogen in athletes.
Clinical hemorheology and microcirculation 2004;30(1):1-8.
2003: Sylvain Poujol; Frédéric Pinguet; Françoise Malosse; Cécile Astre; Marc Ychou; Stéphane Culine; Françoise Bressolle
Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies.
Clinical chemistry 2003;49(11):1900-8.
2003: Salomee Payen; Raphaël Serreau; A Munck; Y Aujard; Y Aigrain; Françoise Bressolle; Evelyne Jacqz-Aigrain
Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.
Antimicrobial agents and chemotherapy 2003;47(10):3170-8.
2003: Marc Ychou; Jacqueline Duffour; Andrew Kramar; Charles Debrigode; Sophie Gourgou; Françoise Bressolle; Frédéric Pinguet
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.
Cancer chemotherapy and pharmacology 2003;52(4):282-90.
2003: Nicolas Mottet; Françoise Bressolle; Vincent Delmas; Michèle Robert; Pierre Costa
Prostatic tissual distribution of alfuzosin in patients with benign prostatic hyperplasia following repeated oral administration.
European urology 2003;44(1):101-5.
2003: Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Roberto Gomeni; Françoise Bressolle
Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes.
International journal of sports medicine 2003;24(4):252-7.
2003: Aurélie Gaudard; Roberto Gomeni; Emmanuelle Varlet-Marie; Michel Audran; Françoise Bressolle
Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes : a population approach.
Clinical drug investigation 2003;23(3):167-79.
2003: Youssef Hijazi; Carole Bodonian; François Salord; Françoise Bressolle; Roselyne Boulieu
Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients.
Clinical drug investigation 2003;23(9):605-9.
2003: Aurélie Gaudard; Emmanuelle Varlet-Marie; Françoise Bressolle; Jacques Mercier; Jean-Frédéric Brun
Hemorheological correlates of fitness and unfitness in athletes: moving beyond the apparent "paradox of hematocrit"?
Clinical hemorheology and microcirculation 2003;28(3):161-73.
2003: Emmanuelle Varlet-Marie; Aurélie Gaudard; Jacques Mercier; Françoise Bressolle; Jean-Frédéric Brun
Is the feeling of heavy legs in overtrained athletes related to impaired hemorheology?
Clinical hemorheology and microcirculation 2003;28(3):151-9.
2003: Emmanuelle Varlet-Marie; Aurélie Gaudard; JF Monnier; Jean-Paul Micallef; Jacques Mercier; Françoise Bressolle; Jean-Frédéric Brun
Reduction of red blood cell disaggregability during submaximal exercise: relationship with fibrinogen levels.
Clinical hemorheology and microcirculation 2003;28(3):139-49.
2003: Emmanuelle Varlet-Marie; Aurélie Gaudard; Jacques Mercier; Françoise Bressolle; Jean-Frédéric Brun
Is whole body impedance a predictor of blood viscosity?
Clinical hemorheology and microcirculation 2003;28(3):129-37.
2003: Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Françoise Bressolle
Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.
Sports medicine (Auckland, N.Z.) 2003;33(4):301-15.
2003: Maud Boucaud; Frédéric Pinguet; Stéphane Culine; Sylvain Poujol; Cécile Astre; Roberto Gomeni; Françoise Bressolle
Modeling plasma and saliva topotecan concentration time course using a population approach.
Oncology research 2003;13(4):211-9.
2003: Aurélie Gaudard; Emmanuelle Varlet-Marie; Françoise Bressolle; Michel Audran
Drugs for increasing oxygen and their potential use in doping: a review.
Sports medicine (Auckland, N.Z.) 2003;33(3):187-212.
2003: Sophie Le Lamer-Déchamps; Patrick Poucheret; Jean-Louis Pérez; Françoise Bressolle
Validation of an inductively coupled plasma-mass spectrometry method to quantify tungsten in human plasma. Determination of percentage binding to plasma proteins.
Clinica chimica acta; international journal of clinical chemistry 2003;327(1-2):39-46.
2002: S Le Lamer-Déchamps; Patrick Poucheret; Gérard Cros; Françoise Bressolle
Influence of food and diabetes on pharmacokinetics of sodium tungstate in rat.
International journal of pharmaceutics 2002;248(1-2):131-9.
2002: Amélie Gauvin; Frédéric Pinguet; Stéphane Culine; Cécile Astre; Roberto Gomeni; Françoise Bressolle
A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer.
Anti-cancer drugs 2002;13(5):473-80.
2002: Amélie Gauvin; Françoise Bressolle; Pierre Martineau; Cécile Astre; Frédéric Pinguet
In vitro schedule-dependent interaction between irinotecan and vinorelbine in NCI H460 non-small cell lung cancer cell line.
Anticancer research 2002;22(2A):905-12.
2002: Sophie Le Lamer; Gérard Cros; Carmen Piñol; Josepha Fernández-Alvarez; Françoise Bressolle
An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats.
Pharmacology & toxicology 2002;90(2):100-5.
2002: Aurélie Gaudard; Emmanuelle Varlet-Marie; JF Monnier; Charles Janbon; Isabelle Quéré; Françoise Bressolle; Jean-Frédéric Brun
Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report.
Clinical hemorheology and microcirculation 2002;27(2):115-22.
2002: Amélie Gauvin; Frédéric Pinguet; Stéphane Culine; Cécile Astre; Didier Cupissol; Françoise Bressolle
Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer.
Cancer chemotherapy and pharmacology 2002;49(1):48-56.
2001: Maud Boucaud; Frédéric Pinguet; Sylvain Poujol; Gilles Romieu; Didier Cupissol; Cécile Astre; Stéphane Culine; Françoise Bressolle
Salivary and plasma pharmacokinetics of topotecan in patients with metastatic epithelial ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(18):2357-64.
2001: Sophie Le Lamer; Gérard Cros; JJ Serrano; C Piñol; J Fernändez-Alvarez; Françoise Bressolle
Estimation of pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in beagle dogs.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;14(4):323-9.
2001: N Cherti; JM Kinowski; Jean-Yves Lefrant; Françoise Bressolle
High-performance liquid chromatographic determination of cefepime in human plasma and in urine and dialysis fluid using a column-switching technique.
Journal of chromatography. B, Biomedical sciences and applications 2001;754(2):377-86.
2001: Christine Farenc; Christine Enjalbal; Pierre Sanchez; Françoise Bressolle; Michel Audran; Jean Martinez; Jean-Louis Aubagnac
Quantitative determination of rocuronium in human plasma by liquid chromatography-electrospray ionization mass spectrometry.
Journal of chromatography. A 2001;910(1):61-7.
2001: Christine Farenc; Jean-Yves Lefrant; Michel Audran; Françoise Bressolle
Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients.
Journal of clinical pharmacology 2001;41(1):44-50.
2000: B Hamel; N Mottet; Michel Audran; P Costa; Françoise Bressolle
Pharmacokinetics of enoxacin and its oxometabolite after multiple oral dosing and penetration into prostatic tissue.
The Journal of antimicrobial chemotherapy 2000;46(6):993-6.
2000: Amélie Gauvin; Frédéric Pinguet; Sylvain Poujol; Cécile Astre; Françoise Bressolle
High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study.
Journal of chromatography. B, Biomedical sciences and applications 2000;748(2):389-99.
2000: Christine Farenc; J R Fabreguette; Françoise Bressolle
Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
Computers and biomedical research, an international journal 2000;33(5):315-29.
2000: Françoise Bressolle; JM Kinowski; J Morel; B Pouly; Jacques Sany; Bernard Combe
Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
The Journal of rheumatology 2000;27(9):2110-4.
2000: Michel Audran; MP Krafft; Jacques de Ceaurriz; J C Maturin; Marie-Therese Sicart; Benedicte Marion; G Bougard; Françoise Bressolle
Determination of perfluorodecalin and perfluoro-N-methylcyclohexylpiperidine in rat blood by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 2000;745(2):333-43.
2000: Sophie Le Lamer; Patrick Poucheret; Gérard Cros; R K de Richter; P A Bonnet; Françoise Bressolle
Pharmacokinetics of sodium tungstate in rat and dog: a population approach.
The Journal of pharmacology and experimental therapeutics 2000;294(2):714-21.
2000: Amélie Gauvin; Frédéric Pinguet; Stéphane Culine; Cécile Astre; Roberto Gomeni; Françoise Bressolle
Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2690-5.
2000: V Orti; Michel Audran; P Gibert; G Bougard; Françoise Bressolle
High-performance liquid chromatographic assay for minocycline in human plasma and parotid saliva.
Journal of chromatography. B, Biomedical sciences and applications 2000;738(2):357-65.
2000: Frédéric Pinguet; Stéphane Culine; Françoise Bressolle; Cécile Astre; M P Serre; C Chevillard; Michel Fabbro
A phase I and pharmacokinetic study of melphalan using a 24-hour continuous infusion in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(1):57-63.
1999: Michel Audran; MP Krafft; Jacques de Ceaurriz; JC Mathurin; Marie-Therese Sicart; Benedicte Marion; F Fabre; Françoise Bressolle
Assay method for the perfluorooctyl bromide (perflubron) in rat blood by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1999;734(2):267-76.
1999: Frédéric Pinguet; Françoise Bressolle; Stéphane Culine; Michel Fabbro; Cécile Astre; C Chevillard
Influence of the schedule of exposure on the cytotoxic effect of melphalan on human 8226 and A2780 cells.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1402-6.
1999: C Guitton; JM Kinowski; M Abbar; P Chabrand; Françoise Bressolle
Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
Journal of clinical pharmacology 1999;39(7):721-8.
1999: Marc Ychou; Jacqueline Duffour; Frédéric Pinguet; Andrew Kramar; JM Joulia; D Topart; Françoise Bressolle
Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer.
Anticancer research 1999;19(3B):2229-35.
1999: Michel Audran; R Gareau; S Matecki; F Durand; C Chenard; Marie-Therese Sicart; Benedicte Marion; Françoise Bressolle
Effects of erythropoietin administration in training athletes and possible indirect detection in doping control.
Medicine and science in sports and exercise 1999;31(5):639-45.
1999: Stéphane Culine; I Roch; Frédéric Pinguet; Gilles Romieu; Françoise Bressolle
Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.
International journal of oncology 1999;14(5):999-1006.
1999: PY Grosse; Françoise Bressolle; Philippe Rouanet; JM Joulia; Frédéric Pinguet
Methyl-beta-cyclodextrin and doxorubicin pharmacokinetics and tissue concentrations following bolus injection of these drugs alone or together in the rabbit.
International journal of pharmaceutics 1999;180(2):215-23.
1999: Christine Farenc; Michel Audran; Jean-Yves Lefrant; I Mazerm; Françoise Bressolle
High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics.
Journal of chromatography. B, Biomedical sciences and applications 1999;724(1):117-26.
1999: JM Joulia; Frédéric Pinguet; Marc Ychou; Jacqueline Duffour; Cécile Astre; Françoise Bressolle
Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid.
European journal of cancer (Oxford, England : 1990) 1999;35(2):296-301.
1999: Françoise Bressolle; JM Joulia; Frédéric Pinguet; Marc Ychou; Cécile Astre; Jacqueline Duffour; Roberto Gomeni
Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer.
Cancer chemotherapy and pharmacology 1999;44(4):295-302.
1999: P Joubert; Françoise Bressolle; A Gouby; P Y Douçot; G Saissi; Roberto Gomeni
A population approach to the forecasting of amikacin plasma and urinary levels using a prescribed dosage regimen.
European journal of drug metabolism and pharmacokinetics 1999;24(1):39-46.
1998: C Guitton; M Abbar; JM Kinowski; P Chabrand; Françoise Bressolle
Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
Journal of clinical psychopharmacology 1998;18(6):470-6.
1998: PY Grosse; Françoise Bressolle; Frédéric Pinguet
Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice.
British journal of cancer 1998;78(9):1165-9.
1998: B Hamel; Michel Audran; P Costa; Françoise Bressolle
Reversed-phase high-performance liquid chromatographic determination of enoxacin and 4-oxo-enoxacin in human plasma and prostatic tissue. Application to a pharmacokinetic study.
Journal of chromatography. A 1998;812(1-2):369-79.
1998: Françoise Bressolle; Roberto Gomeni
Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEM.
Journal of pharmacokinetics and biopharmaceutics 1998;26(3):349-61.
1998: Françoise Bressolle; C Bologna; JM Kinowski; Jacques Sany; Bernard Combe
Effects of moderate renal insufficiency on pharmacokinetics of methotrexate in rheumatoid arthritis patients.
Annals of the rheumatic diseases 1998;57(2):110-3.
1998: C Guitton; JM Kinowski; Roberto Gomeni; Françoise Bressolle
A Kinetic Model for Simultaneous Fit of Clozapine and Norclozapine Concentrations in Chronic Schizophrenic Patients during Long-Term Treatment.
Clinical drug investigation 1998;16(1):35-43.
1998: C Marquer; Françoise Bressolle
Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence.
Fundamental & clinical pharmacology 1998;12(4):377-87.
1998: PY Grosse; Françoise Bressolle; Frédéric Pinguet
In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.
European journal of cancer (Oxford, England : 1990) 1998;34(1):168-74.
1998: PY Grosse; Françoise Bressolle; P Vago; J Simony-Lafontaine; M Radal; Frédéric Pinguet
Tumor cell membrane as a potential target for methyl-beta-cyclodextrin.
Anticancer research 1998;18(1A):379-84.
1997: Françoise Bressolle; C Bologna; JM Kinowski; B Arcos; Jacques Sany; Bernard Combe
Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
The Journal of rheumatology 1997;24(10):1903-9.
1997: JM Joulia; Frédéric Pinguet; Marc Ychou; Jacqueline Duffour; D Topart; PY Grosse; Cécile Astre; Françoise Bressolle
Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2).
Anticancer research 1997;17(4A):2727-30.
1997: PY Grosse; Frédéric Pinguet; JM Joulia; Cécile Astre; Françoise Bressolle
High-performance liquid chromatographic assay for methyl-beta-cyclodextrin in plasma and cell lysate.
Journal of chromatography. B, Biomedical sciences and applications 1997;694(1):219-26.
1997: Françoise Bressolle; Michel Audran; R Gareau; T N Pham; Roberto Gomeni
Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes.
Journal of pharmacokinetics and biopharmaceutics 1997;25(3):263-75.
1997: JM Joulia; Frédéric Pinguet; PY Grosse; Cécile Astre; Françoise Bressolle
Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography: application to a pharmacokinetic study.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(2):427-35.
1997: C Marquer; Françoise Bressolle
High-performance liquid chromatographic determination of the conjugate metabolites of moxisylyte in human plasma and urine.
Journal of chromatography. B, Biomedical sciences and applications 1997;691(2):389-96.
1997: C Guitton; JM Kinowski; R Aznar; Françoise Bressolle
Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection.
Journal of chromatography. B, Biomedical sciences and applications 1997;690(1-2):211-22.
1997: F de Cazanove; JM Kinowski; M Audran; A Rochette; Françoise Bressolle
Determination of nalbuphine in human plasma by high-performance liquid chromatography with electrochemical detection. Application to a pharmacokinetic study.
Journal of chromatography. B, Biomedical sciences and applications 1997;690(1-2):203-10.
1997: PY Grosse; Françoise Bressolle; Frédéric Pinguet
Methyl-beta-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin.
Cancer chemotherapy and pharmacology 1997;40(6):489-94.
1997: S Brandissou; B Hamel; B Veillet; JM Kinowski; N Yagoubi; Françoise Bressolle
[Mycobacterium avium complex infections: the point on the treatments].
Thérapie 1997;52(1):65-71.
1997: Frédéric Pinguet; P Martel; Michel Fabbro; I Petit; Pierre Canal; Stéphane Culine; Cécile Astre; Françoise Bressolle
Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation.
Anticancer research 1997;17(1B):605-11.
1996: Françoise Bressolle; M Audran; T N Pham; J J Vallon
Cyclodextrins and enantiomeric separations of drugs by liquid chromatography and capillary electrophoresis: basic principles and new developments.
Journal of chromatography. B, Biomedical applications 1996;687(2):303-36.
1996: A Souillard; Michel Audran; Françoise Bressolle; P Jaussaud; R Gareau
Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
Biopharmaceutics & drug disposition 1996;17(9):805-15.
1996: Frédéric Pinguet; JM Joulia; P Martel; PY Grosse; Cécile Astre; Françoise Bressolle
High-performance liquid chromatographic assay for melphalan in human plasma. Application to pharmacokinetic studies.
Journal of chromatography. B, Biomedical applications 1996;686(1):43-9.
1996: Françoise Bressolle; M Bromet-Petit; M Audran
Validation of liquid chromatographic and gas chromatographic methods. Applications to pharmacokinetics.
Journal of chromatography. B, Biomedical applications 1996;686(1):3-10.
1996: A Souillard; Michel Audran; Françoise Bressolle; R Gareau; A Duvallet; J L Chanal
Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control.
British journal of clinical pharmacology 1996;42(3):355-64.
1996: Françoise Bressolle; A Gouby; J M Martinez; P Joubert; G Saissi; R Guillaud; Roberto Gomeni
Population pharmacokinetics of amikacin in critically ill patients.
Antimicrobial agents and chemotherapy 1996;40(7):1682-9.
1996: V Augey; P Y Grosse; G Albert; M Audran; Françoise Bressolle
High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
Journal of chromatography. B, Biomedical applications 1996;682(1):125-36.
1996: Pierre Costa; Françoise Bressolle; N Mottet; R Rouzier-Panis; H Navratil; C Marquer
Pharmacokinetics of moxisylyte in healthy volunteers after intravenous infusion and intracavernous administration with and without a penile tourniquet.
Therapeutic drug monitoring 1996;18(2):135-44.
1996: L Edno; Françoise Bressolle; Roberto Gomeni; C Bologna; J Sany; Bernard Combe
Total and free methotrexate pharmacokinetics in rheumatoid arthritis patients.
Therapeutic drug monitoring 1996;18(2):128-34.
1996: Frédéric Pinguet; Françoise Bressolle; P Martel; D Salabert; Cécile Astre
High-performance liquid chromatographic determination of granisetron in human plasma.
Journal of chromatography. B, Biomedical applications 1996;675(1):99-105.
1996: Françoise Bressolle; Pierre Costa; R Rouzier-Panis; C Marquer
Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses.
European journal of clinical pharmacology 1996;49(5):411-5.
1996: Françoise Bressolle; C Bologna; L Edno; J C Bernard; Roberto Gomeni; J Sany; Bernard Combe
A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM.
European journal of clinical pharmacology 1996;49(4):285-92.
1995: M Galtier; D Briand; Frédéric Pinguet; Roberto Gomeni; D Fabre; Françoise Bressolle
Pharmacokinetic parameters of antipyrine in dog after hepatectomy.
Biopharmaceutics & drug disposition 1995;16(8):669-84.
1995: V Augey; M Cociglio; M Galtier; R Yearoo; V Pinsani; Françoise Bressolle
High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum(II) in plasma ultrafiltrate.
Journal of pharmaceutical and biomedical analysis 1995;13(9):1173-8.
1995: F Paganin; Olivier Bouvet; P Chanez; D Fabre; M Galtier; P Godard; F B Michel; Françoise Bressolle
Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation.
Biopharmaceutics & drug disposition 1995;16(5):393-401.
1995: C Bologna; J M Anaya; Françoise Bressolle; C Jorgensen; R Alric; J Sany
Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients.
Clinical and experimental rheumatology 1995;13(4):465-70.
1995: Bernard Combe; L Edno; P Lafforgue; C Bologna; J C Bernard; P Acquaviva; J Sany; Françoise Bressolle
Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.
British journal of rheumatology 1995;34(5):421-8.
1995: L Edno; Françoise Bressolle; Bernard Combe; M Galtier
A reproducible and rapid HPLC assay for quantitation of piroxicam in plasma.
Journal of pharmaceutical and biomedical analysis 1995;13(6):785-9.
1995: JM Kinowski; M Rodier; Françoise Bressolle; D Fabre; V Augey; J L Richard; M Galtier; R Gomen
Bayesian estimation of p-aminohippurate clearance by a limited sampling strategy.
Journal of pharmaceutical sciences 1995;84(3):307-11.
1995: M Favier; F de Cazanove; Françoise Bressolle; F Bons; E Coste; M Galtier
Pharmacist development and use of antiemetic protocols.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(3):319-20.
1994: C Bologna; L Edno; J M Anaya; François Canovas; M Vanden Berghe; C Jorgensen; M Galtier; Bernard Combe; Françoise Bressolle; J Sany
Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients.
Arthritis and rheumatism 1994;37(12):1770-3.
1994: Françoise Bressolle; F Gonçalves; A Gouby; M Galtier
Pefloxacin clinical pharmacokinetics.
Clinical pharmacokinetics 1994;27(6):418-46.
1994: D Fabre; Françoise Bressolle; JM Kinowski; Olivier Bouvet; F Paganin; M Galtier
A reproducible, simple and sensitive HPLC assay for determination of ofloxacin in plasma and lung tissue. Application in pharmacokinetic studies.
Journal of pharmaceutical and biomedical analysis 1994;12(11):1463-9.
1994: Françoise Bressolle; Roberto Gomeni; R Alric; M J Royer-Morrot; J Necciari
A double Weibull input function describes the complex absorption of sustained-release oral sodium valproate.
Journal of pharmaceutical sciences 1994;83(10):1461-4.
1994: Françoise Bressolle; M Galtier; JM Kinowski; F Goncalves; L Edno; R Panis; Roberto Gomeni
Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
Journal of pharmaceutical sciences 1994;83(9):1236-40.
1994: Françoise Bressolle; JM Kinowski; Jean E de La Coussaye; N Wynn; Jean-Jacques Eledjam; M Galtier
Clinical pharmacokinetics during continuous haemofiltration.
Clinical pharmacokinetics 1994;26(6):457-71.
1994: JM Kinowski; Françoise Bressolle; D Fabre; F Goncalves; R Rouzier-Panis; M Galtier
High-performance liquid chromatographic determination of ceftibuten and its metabolite in biological fluids: applications in pharmacokinetic studies.
Journal of pharmaceutical sciences 1994;83(5):736-41.
1994: M Favier; F de Cazanove; F Saint-Martin; Françoise Bressolle
Preventing medication errors in antineoplastic therapy.
American journal of hospital pharmacy 1994;51(6):832-3.
1994: J M Anaya; D Fabre; Françoise Bressolle; C Bologna; R Alric; M Cocciglio; R Dropsy; J Sany
Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
The Journal of rheumatology 1994;21(2):203-8.
1993: Françoise Bressolle; J M Laurelli; Roberto Gomeni; J G Bechier; N R Wynn; M Galtier; Jean-Jacques Eledjam
A Weibull distribution model for intradermal administration of ceftazidime.
Journal of pharmaceutical sciences 1993;82(11):1175-8.
1993: M Galtier; Françoise Bressolle; Jean E de La Coussaye; Roberto Gomeni; P Joubert; F Gény; A Dubois; C Raffanel; G Saissi; Jean-Jacques Eledjam
Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency.
Clinical pharmacokinetics 1993;25(5):415-23.
1993: M Favier; S Hansel; Françoise Bressolle
Preparing cytotoxic agents in an isolator.
American journal of hospital pharmacy 1993;50(11):2335-9.
1993: Pierre Costa; Françoise Bressolle; E Jarroux; B Sarrazin; J Mosser; H Navratil; M Galtier
Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers.
Journal of pharmaceutical sciences 1993;82(9):968-71.
1993: Pierre Costa; Françoise Bressolle; B Sarrazin; J Mosser; M Galtier
Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and intracavernous administration.
Journal of pharmaceutical sciences 1993;82(7):729-33.
1993: D Fabre; Françoise Bressolle; R Goméni; Olivier Bouvet; A Dubois; C Raffanel; Jean-Christophe Gris; M Galtier
Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.
Clinical pharmacokinetics 1993;24(4):333-43.
1993: Pierre Costa; Françoise Bressolle; B Sarrazin; J Mosser; R Sabatier
Dose-related effect of moxisylyte on maximal urethral closing pressure in patients with spinal cord injuries.
Clinical pharmacology and therapeutics 1993;53(4):443-9.
1993: JM Kinowski; Jean E de La Coussaye; Françoise Bressolle; D Fabre; G Saissi; Olivier Bouvet; M Galtier; Jean-Jacques Eledjam
Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration.
Antimicrobial agents and chemotherapy 1993;37(3):464-73.
1993: Pierre Costa; B Sarrazin; Françoise Bressolle; M H Colson; P Bondil; F Saudubray
Efficiency and side effects of intracavernous injections of moxisylyte in impotent patients: a dose-finding study versus placebo.
The Journal of urology 1993;149(2):301-5.
1993: Pierre Costa; B Sarrazin; Françoise Bressolle; Nicolas Mottet; Jean-François Louis; F Saudubray; H Navratil
Is the volume injected a parameter likely to influence the erectile response observed after intracavernous administration of an alpha-blocking agent?
European urology 1993;24(1):43-7.
1992: Pierre Costa; Françoise Bressolle; M Bromet-Petit; J Mosser; B Sarrazin
Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and oral administration.
Journal of pharmaceutical sciences 1992;81(12):1223-6.
1992: Pierre Costa; Françoise Bressolle; B Sarrazin; J Mosser; H Navratil; M Galtier
Moxisylyte plasma kinetics in humans after intracavernous administration.
Biopharmaceutics & drug disposition 1992;13(9):671-9.
1992: Françoise Bressolle; Jean E de La Coussaye; R Ayoub; D Fabre; Roberto Gomeni; G Saissi; Jean-Jacques Eledjam; M Galtier
Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability.
Antimicrobial agents and chemotherapy 1992;36(7):1404-11.
1992: Olivier Bouvet; Françoise Bressolle; C Courtieu; M Galtier
Penetration of pefloxacin into gynaecological tissues.
The Journal of antimicrobial chemotherapy 1992;29(5):579-87.
1992: J M Jacquet; M Galtier; Françoise Bressolle; J Jourdan
A sensitive and reproducible HPLC assay for doxorubicin and pirarubicin.
Journal of pharmaceutical and biomedical analysis 1992;10(5):343-8.
1992: Françoise Bressolle; J M Jacquet; M Galtier; J Jourdan; D Donadio; J F Rossi
Doxorubicin and doxorubicinol plasma concentrations and excretion in parotid saliva.
Cancer chemotherapy and pharmacology 1992;30(3):215-8.
1992: Françoise Bressolle; J Brès; A Fauré-Jeantis
Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans.
Journal of pharmaceutical sciences 1992;81(1):26-32.
1991: J Brès; Françoise Bressolle
Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations.
Journal of pharmaceutical sciences 1991;80(12):1119-24.
1991: D Fabre; Françoise Bressolle; Roberto Gomeni; C Arich; F Lemesle; H Beziau; M Galtier
Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.
Antimicrobial agents and chemotherapy 1991;35(12):2521-5.
1991: Françoise Bressolle; P Joubert; A Gouby; P Costa; M Laracine; T Rebière
Altered tobramycin pharmacokinetics during chemoprophylaxis in bladder surgery.
Antimicrobial agents and chemotherapy 1991;35(7):1454-9.
1991: Françoise Bressolle; P Ray; J M Jacquet; J Brès; M Galtier; D Donadio; J Jourdan; J F Rossi
Bayesian estimation of doxorubicin pharmacokinetic parameters.
Cancer chemotherapy and pharmacology 1991;29(1):53-60.
1990: J M Jacquet; Françoise Bressolle; M Galtier; M Bourrier; D Donadio; J Jourdan; J F Rossi
Doxorubicin and doxorubicinol: intra- and inter-individual variations of pharmacokinetic parameters.
Cancer chemotherapy and pharmacology 1990;27(3):219-25.
1989: Françoise Bressolle; J Brès; G Mourad
Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.
Clinical pharmacokinetics 1989;17(5):367-73.